tradmap

NHI Financials National Health Investors Inc

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Financial health

  • Total debt ($1.2B) exceeds cash ($20M); net debt is $1.1B.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 119.4% of earnings.
  • The dividend has declined 2.7% per year over the past 5 years.
Revenue & net income
$0 $93M $185M 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 139% 278% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 10% 20% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$550M -$188M $174M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $750M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$626M -$51M $524M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $80M $142M 0.0% 0.0% 9.3% 5.1% -$57M $1.2B $20M
2024 $54M $138M 0.0% 0.0% 10.1% 5.3% $50M $1.1B $24M
2023 $49M $136M 0.0% 0.0% 10.8% 5.5% $135M $1.1B $22M
2022 $36M $66M 0.0% 0.0% 5.2% 2.6% $174M $1.1B $19M
2021 $0 $112M — — 7.4% 3.9% $161M $1.2B $37M
2020 $0 $185M — — 12.2% 5.9% $115M $1.5B $43M
2019 — $160M — — 10.7% 5.3% $4M $1.4B $5M
2018 — $154M — — 11.1% 5.6% $60M $1.3B $5M
2017 — $159M — — 12.1% 6.3% $22M $1.1B $3M
2016 — $152M — — 12.5% 6.3% -$218M $1.1B $5M
2015 — $149M — — 13.1% 7.0% $40M $914M $13M
2014 — $102M — — 9.8% 5.1% -$407M $863M $3M
2013 — $106M — — 13.9% 7.3% -$550M $617M $11M
2012 — $91M — — 19.8% 12.9% -$24M $203M $9M
2011 — $81M — — 18.3% 14.0% $1M $97M $16M

Valuation over time

How the market has priced NHI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 20.7 41.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 42.3 84.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 3.3 6.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is NHI growing its revenue and profit?

See the revenue and net-income charts above for National Health Investors Inc's multi-year trend.

How much debt does NHI have?

As of FY2025, National Health Investors Inc reported $1.2B of total debt against $20M of cash.

What is NHI's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin 177.6%.

What is NHI's P/E ratio?

National Health Investors Inc's P/E (TTM) is 20.26 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the NHI stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 23.8× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.